All Posts

Proseek Bio is delighted to announce that Kirsty Garrett has joined us as Board Chair. Kirsty is an accomplished and forward-thinking leader with more than 35 years of experience, much of it in the high-growth technology sector. She joins us at an important moment, as we continue building the foundations to bring new blood-based diagnostic tools from the lab into clinical practice. Building and scaling in digital health Kirsty brings direct operating experience from the CEO s

Every year, thousands of women are told they have a suspicious ovarian mass. It's a sentence that changes everything in an instant, and for most of them, the only way to find out what it actually means is surgery. It's the part after that people are often surprised to learn. A large proportion of women who undergo surgery for a suspicious ovarian mass turn out not to have cancer at all [1]. The mass was benign. The surgery, with all its risks, recovery time and emotional weig

We're delighted to announce that Dr. David Herold, MD, PhD, has joined Proseek Bio as our first Clinical Advisor. It's a milestone moment for us. As we continue developing our blood test to help clinicians better assess suspicious ovarian masses, and work toward closing the diagnostic gap in women's health, having someone of David's calibre and experience guiding us is invaluable. About Dr. David Herold David brings decades of expertise in clinical pathology and mass spectrom